Article
Using ‘omics’ to define pathogenesis and biomarkers of Parkinson’s disease
1 Jun 2010
Abstract excerpt
Although great effort has been put forth to uncover the complex molecular mechanisms exploited in the pathogenesis of Parkinson's disease, a satisfactory explanation remains to be discovered. The emergence of several -omics techniques, transcriptomics, proteomics and metabolomics, have been integral in confirming previously identified pathways that are associated with dopaminergic neurodegeneration and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
